MXPA05006505A - Composiciones vaginales de sertaconazol. - Google Patents

Composiciones vaginales de sertaconazol.

Info

Publication number
MXPA05006505A
MXPA05006505A MXPA05006505A MXPA05006505A MXPA05006505A MX PA05006505 A MXPA05006505 A MX PA05006505A MX PA05006505 A MXPA05006505 A MX PA05006505A MX PA05006505 A MXPA05006505 A MX PA05006505A MX PA05006505 A MXPA05006505 A MX PA05006505A
Authority
MX
Mexico
Prior art keywords
sertaconazole
pharmaceutical compositions
vaginal use
vaginal
monodose
Prior art date
Application number
MXPA05006505A
Other languages
English (en)
Inventor
Romero Alfonso
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of MXPA05006505A publication Critical patent/MXPA05006505A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invencion se refiere a composiciones vaginales de sertaconazol y mas especificamente a composiciones vaginales de sertaconazol de uso en el tratamiento de candidiasis vulvovaginal.
MXPA05006505A 2002-12-18 2003-12-17 Composiciones vaginales de sertaconazol. MXPA05006505A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0214488 2002-12-18
PCT/EP2003/014422 WO2004054576A1 (en) 2002-12-18 2003-12-17 Pharmaceutical compositions of sertaconazole for vaginal use

Publications (1)

Publication Number Publication Date
MXPA05006505A true MXPA05006505A (es) 2005-09-30

Family

ID=32523981

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006505A MXPA05006505A (es) 2002-12-18 2003-12-17 Composiciones vaginales de sertaconazol.

Country Status (18)

Country Link
US (1) US20060165803A1 (es)
EP (1) EP1572201B1 (es)
JP (1) JP2006513182A (es)
KR (1) KR20050084294A (es)
CN (1) CN1726032A (es)
AT (1) ATE400270T1 (es)
AU (1) AU2003290071A1 (es)
BR (1) BR0317555A (es)
CA (1) CA2509830A1 (es)
DE (1) DE60322103D1 (es)
EA (1) EA010155B1 (es)
GE (1) GEP20074224B (es)
HR (1) HRP20050574A2 (es)
IS (1) IS7928A (es)
MA (1) MA27498A1 (es)
MX (1) MXPA05006505A (es)
NO (1) NO20053398L (es)
WO (1) WO2004054576A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
WO2009010986A1 (en) * 2007-07-19 2009-01-22 Glenmark Pharmaceuticals Limited Topical cream compositions of sertaconazole nitrate
EP2508174A1 (en) * 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2014349132A1 (en) * 2013-10-22 2016-04-14 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositons and methods
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
CN113197851A (zh) * 2015-05-06 2021-08-03 辛纳吉勒公司 包含药物粒子的药用悬浮液、用于其配给的装置、以及其使用方法
US10004683B2 (en) 2015-06-18 2018-06-26 Common Pharma, Inc. Antimicrobial formulations
EP3310363A4 (en) * 2015-06-18 2019-02-13 Common Pharma, Inc ANTIMICROBIAL FORMULATIONS
CN106109398A (zh) * 2016-06-14 2016-11-16 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶
CN106038477A (zh) * 2016-06-14 2016-10-26 上海通用药业股份有限公司 一种含有噻康唑的阴道用凝胶的制备方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN112691075B (zh) * 2020-12-31 2023-06-20 海南海神同洲制药有限公司 一种硝酸舍他康唑乳膏及其制备方法
CN112791048B (zh) * 2020-12-31 2023-01-17 海南海神同洲制药有限公司 一种硝酸舍他康唑栓及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2847011A (en) * 1956-08-14 1958-08-12 Ortho Pharma Corp Single dose applicator
US4551148A (en) * 1982-09-07 1985-11-05 Kv Pharmaceutical Company Vaginal delivery systems and their methods of preparation and use
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5514698A (en) * 1994-03-21 1996-05-07 Ortho Pharmaceutical Corporation Antifungal vaginal cream composition
IT1284874B1 (it) * 1996-08-02 1998-05-22 Farmigea Spa Complessi bioadesivi di polycarbophil e farmaci antifungini o antiprotozoari azolici
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6153635A (en) * 1998-11-20 2000-11-28 Upmalis; David H. Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030091540A1 (en) * 2001-10-16 2003-05-15 Nawaz Ahmad Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity

Also Published As

Publication number Publication date
US20060165803A1 (en) 2006-07-27
CA2509830A1 (en) 2004-07-01
NO20053398D0 (no) 2005-07-13
ATE400270T1 (de) 2008-07-15
NO20053398L (no) 2005-09-06
BR0317555A (pt) 2005-11-22
EA200501008A1 (ru) 2005-12-29
EA010155B1 (ru) 2008-06-30
IS7928A (is) 2005-07-01
JP2006513182A (ja) 2006-04-20
AU2003290071A1 (en) 2004-07-09
DE60322103D1 (de) 2008-08-21
EP1572201B1 (en) 2008-07-09
CN1726032A (zh) 2006-01-25
HRP20050574A2 (en) 2006-06-30
KR20050084294A (ko) 2005-08-26
WO2004054576A1 (en) 2004-07-01
EP1572201A1 (en) 2005-09-14
GEP20074224B (en) 2007-10-25
MA27498A1 (fr) 2005-08-01

Similar Documents

Publication Publication Date Title
NO20053398D0 (no) Farmasoytiske preparater av sertaconazol for vaginal anvendelse.
DE60329001D1 (en) 8-hydroxychinolinderivate
UA84141C2 (ru) Применение ингибитора пктжк для лечения или профилактики запора
HK1094425A1 (en) Substituted 2-aminotetralines for the preventive treatment of parkinson's disease
TW200716614A (en) Substituted arylpyrazoles
EP1602370A3 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
DE602004011394D1 (en) Thiazolderivate
MX2008001546A (es) 3,11b-cis-dihidrotetrabenazina para el tratamiento de una enfermedad proliferativa o una inflamacion.
MY148125A (en) Compounds
ZA200806778B (en) N-Hydroxyacrylamide compounds
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
MX2009001660A (es) Compuestos de 2,5-dihidroxibenceno para el tratamiento de psoriasis.
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
MXPA04006031A (es) Compuestos para el tratamiento de trastornos inflamatorios.
MXPA04001968A (es) Agentes antidiabeticos.
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
GEP20074127B (en) Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
DE60114640D1 (en) Antithrombosemittel
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
TW200531690A (en) Pharmaceutical compositions of sertaconazole for vaginal use
GB0325605D0 (en) Combination of organic compounds

Legal Events

Date Code Title Description
FG Grant or registration